VSY Biotechnology Launches Enova, the First 100% Glistening Free

Hydrophobic Acrylic IOL that does not Require Pre-hydration and Storage in Saline Solution!

VSY Biotechnology announces Enova, the first 100% glistening-free hydrophobic acrylic IOL that requires neither pre-hydration nor storage in saline. Enova is packaged dry and has excellent optical and mechanical properties.

Leinfelden-Echterdingen, Germany July 22, 2020 ­- VSY Biotechnology GmbH, an innovation driven company with its progressive R&D activities in ophthalmology, today announces the newest family member Enova, 100% Glistening-free IOL. Enova is the first 100% Glistening-free hydrophobic acrylic IOL that does not require pre-hydration or storage in saline solution.

Next Generation Hydrophobic IOLs

Unique composition of Enova material allows uniform hydration of specific sites to have controlled water uptake and resistance to glistening formation. Glistening study was performed at the Intermountain Ocular Research Center (Mamalis/Werner Laboratory), John A. Moran Eye Center, University of Utah and the unique composition of Enova hydrophobic acrylic IOL shows no glistening compared with other IOLs.

Enova is the first 100% glistening-free hydrophobic acrylic IOL that requires neither pre-hydration nor storage in saline. Enova is packaged dry and has excellent optical and mechanical properties.

Outstanding Biomechanical Properties

Glass transition temperature of a polymer is the temperature where the polymer changes from a rigid material to a soft material. Having a Tg -2°C, Enova IOL has gentle and controlled unfolding process below standard operating room temperatures. Thus, no warming or special conditioning is required. Low glass transition temperature (Tg -2°C) combined with its optimized modulus of elasticity, provides a high level of flexibility and controlled unfolding.

For more information, visit https://www.vsybiotechnology.com/enova/, contact your sales representative or email us at info@vsybiotechnology.com.

About VSY Biotechnology GMBH

VSY Biotechnology GmbH is an innovation driven company with its progressive R&D activities in ophthalmology, orthopedics, aesthetics and biotechnologic drugs. VSY Biotechnology focuses on developing, designing and manufacturing superior state-of-the-art products to serve doctors, patients and consumers beyond their expectations.

START TYPING AND PRESS ENTER TO SEARCH